Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Dyax Corp. (NASDAQ: DYAX) today announced financial results for the second quarter ended June 30, 2013. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and provide updates regarding its key value drivers – the KALBITOR® (ecallantide) business, DX-2930 and the Licensing and Funded Research Program (LFRP).
Help employers find you! Check out all the jobs and post your resume.
